Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy Stock

Showing results (21-30 of 322) with videos related to

Pageof 33
Sort By:
Clinical Lymphoma & Myeloma|September 26, 2009
Burkitt lymphoma/leukemia: improving prognosisVaishalee P Kenkre, Wendy Stock
Best Practice & Research. Clinical Haematology|November 24, 2018
Should immunologic strategies be incorporated into frontline ALL therapy?Cecilie Utke Rank, Wendy Stock
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 17, 2016
The Persistence of Minimal Residual Disease in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: We Know It's Bad, Now What?Jessica T Leonard, Wendy Stock
Blood Advances|January 10, 2019
Inotuzumab: from preclinical development to success in B-cell acute lymphoblastic leukemiaJoseph Wynne, David Wright, Wendy Stock
Journal of Homosexuality|June 29, 2006
Investigating bias in psychotherapy with BDSM clientsKeely Kolmes, Wendy Stock, Charles Moser
Clinical Lymphoma, Myeloma & Leukemia|July 15, 2018
Molecular Minimal Residual Disease Testing in Acute Myeloid Leukemia: A Review for the Practicing ClinicianAndrew Hantel, Wendy Stock, Satyajit Kosuri
Clinical Advances in Hematology & Oncology : H&O|May 10, 2018
Management of acute lymphoblastic leukemia in young adultsLori S Muffly, Natalie Reizine, Wendy Stock
Current Opinion in Hematology|February 7, 2013
Expanded indications for allogeneic stem cell transplantation in patients with myeloid malignanciesHongtao Liu, Wendy Stock, Michael R Bishop
Hematology/Oncology Clinics of North America|October 15, 2009
Looking toward the future: novel strategies based on molecular pathogenesis of acute lymphoblastic leukemiaSyed A Abutalib, Meir Wetzler, Wendy Stock
Leukemia & Lymphoma|June 9, 2016
Incorporating measurable ('minimal') residual disease-directed treatment strategies to optimize outcomes in adults with acute myeloid leukemiaKristen Pettit, Wendy Stock, Roland B Walter
Pageof 33

Showing results (21-30 of 322) with videos related to

Sort By:
Pageof 33
Clinical Lymphoma & Myeloma|September 26, 2009
Burkitt lymphoma/leukemia: improving prognosisVaishalee P Kenkre, Wendy Stock
Best Practice & Research. Clinical Haematology|November 24, 2018
Should immunologic strategies be incorporated into frontline ALL therapy?Cecilie Utke Rank, Wendy Stock
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 17, 2016
The Persistence of Minimal Residual Disease in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: We Know It's Bad, Now What?Jessica T Leonard, Wendy Stock
Blood Advances|January 10, 2019
Inotuzumab: from preclinical development to success in B-cell acute lymphoblastic leukemiaJoseph Wynne, David Wright, Wendy Stock
Journal of Homosexuality|June 29, 2006
Investigating bias in psychotherapy with BDSM clientsKeely Kolmes, Wendy Stock, Charles Moser
Clinical Lymphoma, Myeloma & Leukemia|July 15, 2018
Molecular Minimal Residual Disease Testing in Acute Myeloid Leukemia: A Review for the Practicing ClinicianAndrew Hantel, Wendy Stock, Satyajit Kosuri
Clinical Advances in Hematology & Oncology : H&O|May 10, 2018
Management of acute lymphoblastic leukemia in young adultsLori S Muffly, Natalie Reizine, Wendy Stock
Current Opinion in Hematology|February 7, 2013
Expanded indications for allogeneic stem cell transplantation in patients with myeloid malignanciesHongtao Liu, Wendy Stock, Michael R Bishop
Hematology/Oncology Clinics of North America|October 15, 2009
Looking toward the future: novel strategies based on molecular pathogenesis of acute lymphoblastic leukemiaSyed A Abutalib, Meir Wetzler, Wendy Stock
Leukemia & Lymphoma|June 9, 2016
Incorporating measurable ('minimal') residual disease-directed treatment strategies to optimize outcomes in adults with acute myeloid leukemiaKristen Pettit, Wendy Stock, Roland B Walter
Pageof 33